Related Experiment Video
Updated: May 13, 2026
07:08
Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency
Published on: February 2, 2024
Locally advanced pancreatic cancer
Georgios M Oikonomopoulos1, Kathryn E Huber, Konstantinos N Syrigos
1Second Oncology Clinic, St. Savvas Anticancer Hospital, Athens, Greece. goik77@yahoo.com
JOP : Journal of the Pancreas
|March 12, 2013
Summary
Treatment for advanced pancreatic cancer is palliative, focusing on chemotherapy and chemoradiotherapy. Research explores new, less toxic regimens beyond gemcitabine for better patient outcomes.
Area of Science:
- Oncology
- Gastrointestinal Oncology
Background:
- Treatment for locally advanced pancreatic cancer is primarily palliative.
- Current palliative care often involves chemotherapy, with chemoradiotherapy considered based on patient response.
Purpose of the Study:
- To summarize and discuss novel treatment strategies for locally advanced pancreatic cancer.
- To explore chemotherapy and chemoradiotherapy regimens moving beyond traditional gemcitabine-based treatments.
- To identify therapeutic combinations that are both less toxic and more effective.
Main Methods:
- Review and synthesis of three abstracts (#LBA146, #256, #303) presented at the 2013 ASCO Gastrointestinal Cancers Symposium.
- Discussion of alternative chemotherapy and chemoradiotherapy regimens.
- Analysis of efforts to develop less toxic and more efficient treatment options.
Main Results:
- The abstracts focused on treatment approaches for locally advanced pancreatic cancer.
- There is a shift towards exploring regimens that deviate from standard gemcitabine-based chemotherapy.
- Ongoing research aims to find therapeutic combinations with improved toxicity profiles and efficacy.
Conclusions:
- Newer chemotherapy and chemoradiotherapy regimens are being investigated for locally advanced pancreatic cancer.
- The focus is on developing treatments that offer a better balance of efficacy and reduced toxicity compared to gemcitabine.
- Further research is needed to establish optimal, less toxic treatment strategies.
